Author:
Yuan Ruoshi,Zhu Xiaomei,Radich Jerald P.,Ao Ping
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. National Cancer Institute, Bethesda, MD. SEER Cancer Statistics Factsheets: Leukemia. URL http://seer.cancer.gov/statfacts/html/leuks.html . (2012) (Date of access:10/02/2016).
2. Wang, Z.-Y. & Chen, Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111, 2505–2515 (2008).
3. Marchwicka, A., Cebrat, M., Sampath, P., Śnieżewski, Ł. & Marcinkowska, E. Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients’ variable responses to 1,25-dihydroxyvitamin D and vitamin D analogs. Front. Oncol. 4, 125 (2014).
4. Lo-Coco, F. & Hasan, S. K. Understanding the molecular pathogenesis of acute promyelocytic leukemia. Best Pract. Res. Clin. Hematol. 27, 3–9 (2014).
5. Kogan, S. C. Mouse models of acute promyelocytic leukemia. In Pandolfi, P. & Vogt, P. (eds.) Acute Promyelocytic Leukemia vol. 313 of Current Topics in Microbiology and Immunology 3–29 (Springer, Berlin, 2007).